Information and Communication on Risks Related to Medications and Proper Use of Medications for Healthcare Professionals and the General Public: Precautionary Principle, Risk Management, Communication During and in the Absence of Crisis Situations

被引:2
作者
Molimard, Mathieu [1 ,2 ]
Bernaud, Corine [3 ]
Lechat, Philippe [4 ]
Bejan-Angoulvant, Theodora [5 ]
Benattia, Cherif [6 ]
Benkritly, Amel [7 ]
Braunstein, David [8 ]
Cabut, Sandrine [9 ]
David, Nadine [10 ]
Fourrier-Reglat, Annie [11 ]
Gallet, Benoit [12 ]
Gersberg, Marta [13 ]
Goni, Sylvia [14 ]
Jolliet, Pascale [15 ]
Lamarque-Garnier, Veronique [16 ]
Le Jeunne, Claire [17 ]
Leurs, Irina [18 ]
Liard, Francois [19 ]
Malbezin, Muriel [20 ]
Micallef, Joelle [8 ]
Nguon, Marina [21 ]
机构
[1] CHU, F-33076 Bordeaux, France
[2] Univ Bordeaux, Dept Pharmacol, F-33076 Bordeaux, France
[3] Lab AstraZeneca France, Direct Med, Rueil Malmaison, France
[4] Hop St Louis, AP HP, Dept Rech Clin & Dev, Paris, France
[5] CHU Tours, Tours, France
[6] Suniv Pharmaceut, Marlborough, MA USA
[7] Lab Sanofi Aventis, Paris, France
[8] CHU Timone, CIC, CPCET, AP HM, Marseille, France
[9] Le Monde, Paris, France
[10] Direct Gen Sante, Paris, France
[11] Univ Bordeaux, F-33076 Bordeaux, France
[12] Lab Bristol Myers Squibb, Paris, France
[13] MGersberg Conseil, Chatou, France
[14] Lab Lundbeck, Issy Les Moulineaux, France
[15] CHU, Nantes, France
[16] SFPT, Croissy Sur Seine, France
[17] Hop Hotel Dieu, AP HP, Paris, France
[18] Lab Norgine, Rueil Malmaison, France
[19] Cabinet Med, St Epain, France
[20] Lab Janssen Cilag, Issy Les Moulineaux, France
[21] Hop St Louis, AP HP, Paris, France
来源
THERAPIE | 2014年 / 69卷 / 04期
关键词
information; communication; training; proper use of medications; risks of medications;
D O I
10.2515/therapie/2014045
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recent drug crises have highlighted the complexity, benefits and risks of medication communication. The difficulty of this communication is due to the diversity of the sources of information and the target audience, the credibility of spokespersons, the difficulty to communicate on scientific uncertainties and the precautionary principle, which is influenced by variable perceptions and tolerances of the risk. Globally, there is a lack of training in risk management with a tendency of modern society to refuse even the slightest risk. Communication on medications is subject to regulatory or legal requirements, often uses tools and messages that are not adapted to the target audience and is often based on a poor knowledge of communication techniques. In order to improve this situation, the available information must be coordinated by reinforcing the unique medication information website and by coordinating communication between authorities by means of a single spokesperson. A particular effort must be made in the field of training in the proper use and risk of medications for both the general population and patients but also for healthcare professionals, by setting up a unified academic on-line teaching platform for continuing medical education on medications and their proper use.
引用
收藏
页码:361 / 366
页数:6
相关论文
共 3 条
  • [1] Begaud B, 2013, Rapport sur la surveillance et la promotion du bon usage du medicament en France
  • [2] European Medicines Agency (EMA), 2013, GUID GOOD PHARM PRAC
  • [3] Evaluation of the impact of the recent controversy over statins in France: The EVANS study
    Saib, Anis
    Sabbah, Laurent
    Perdrix, Ludivine
    Blanchard, Didier
    Danchin, Nicolas
    Puymirat, Etienne
    [J]. ARCHIVES OF CARDIOVASCULAR DISEASES, 2013, 106 (10) : 511 - 516